Fig. 5: Subgroup analysis of progression-free survival per rearrangement status.
MYC-R patients treated with R2CHOP in blue versus R-CHOP in red in an unadjusted comparison depicted for A single-hit patients and B double/triple-hit patients.
Fig. 5: Subgroup analysis of progression-free survival per rearrangement status. | Blood Cancer Journal
